Xiaoxiao Guo

1.4k total citations
93 papers, 917 citations indexed

About

Xiaoxiao Guo is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Xiaoxiao Guo has authored 93 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pulmonary and Respiratory Medicine, 24 papers in Cardiology and Cardiovascular Medicine and 24 papers in Oncology. Recurrent topics in Xiaoxiao Guo's work include Pulmonary Hypertension Research and Treatments (22 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Cardiovascular Function and Risk Factors (8 papers). Xiaoxiao Guo is often cited by papers focused on Pulmonary Hypertension Research and Treatments (22 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Cardiovascular Function and Risk Factors (8 papers). Xiaoxiao Guo collaborates with scholars based in China, United States and United Kingdom. Xiaoxiao Guo's co-authors include Quan Fang, Xiaofeng Zeng, Yongtai Liu, Zhuang Tian, Qian Wang, Jiuliang Zhao, Jiaxin Zhou, Mengtao Li, Jinzhi Lai and Hanping Wang and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Xiaoxiao Guo

83 papers receiving 910 citations

Peers

Xiaoxiao Guo

PRM

CCM

ONCOL

IMMUN

Lars Harbaum Germany

Lavinia Maegel Germany

Véronique Latger‐Cannard France

Uta Erdbrüegger Germany

Hideo Kagawa Japan

Cédric Garcia France

Maria Carmela Epistolato Italy

Sabri Barutça Türkiye

D. Garth Perkins Canada

Lars Harbaum Germany

Xiaoxiao Guo

388 ×0.9

PRM

126 ×0.6

CCM

321 ×1.7

ONCOL

98 ×0.7

IMMUN

201 ×1.4

Citations per year, relative to Xiaoxiao Guo Xiaoxiao Guo (= 1×) peers Lars Harbaum

Countries citing papers authored by Xiaoxiao Guo

Since Specialization

Citations

This map shows the geographic impact of Xiaoxiao Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxiao Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxiao Guo more than expected).

Fields of papers citing papers by Xiaoxiao Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxiao Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxiao Guo. The network helps show where Xiaoxiao Guo may publish in the future.

Co-authorship network of co-authors of Xiaoxiao Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxiao Guo. A scholar is included among the top collaborators of Xiaoxiao Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxiao Guo. Xiaoxiao Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qin, Xiaohan, et al.. (2025). Sodium‐Glucose Cotransporter‐2 Inhibitors and Diabetic‐Ketoacidosis in T2DM Patients: An Updated Meta‐Analysis and a Mendelian Randomization Analysis. Clinical Pharmacology & Therapeutics. 117(6). 1661–1669. 1 indexed citations

Jiang, Hui, Yangzhong Zhou, Liying Peng, et al.. (2025). Impact of antiphospholipid antibodies on heart valve involvements in systemic lupus erythematosus: based on CSTAR cohort. Lupus Science & Medicine. 12(1). e001674–e001674.

Bai, Xue, Jing Hu, Hui Zheng, et al.. (2025). Clinicopathological Features and Prognoses of Patients With Splenic Metastases From Breast Cancer: A Single-Centre, Retrospective Study. Cancer Control. 32. 2925728626–2925728626.

Guo, Xiaoxiao, et al.. (2025). RE: Personalized starting age of gastric cancer screening based on individuals’ risk profiles: a population-based, prospective study. JNCI Journal of the National Cancer Institute. 117(10). 2138–2139.

Li, Jingyao, et al.. (2025). Sustainable Zinc–Air Batteries: Innovations, Challenges, and Pathways to Commercialization. Small. 21(49). e08482–e08482.

Zhang, Jing, Xiaohan Qin, Yuhan Qin, et al.. (2025). Proteomic- and metabolomic-based mechanisms of androgen-mediated right ventricular maladaptive remodeling under pressure overload. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(5). 167768–167768. 1 indexed citations

Chen, Xiaoniao, Yunxiao Xie, Xiuyan Zhang, et al.. (2024). Lactylome analysis reveals potential target modified proteins in the retina of form-deprivation myopia. iScience. 27(9). 110606–110606. 7 indexed citations

Guo, Xiaoxiao, Xiuyan Zhang, Qiuxin Wu, et al.. (2023). Application of Artificial Intelligence to Quantitative Assessment of Fundus Tessellated Density in Young Adults with Different Refractions. Ophthalmic Research. 66(1). 706–716. 6 indexed citations

Guo, Xiaoxiao, Xiaomin Song, Junling Pang, et al.. (2022). The role of immunoglobulin E and mast cells in hypertension. Cardiovascular Research. 118(14). 2985–2999. 22 indexed citations

10.

Zhou, Yong, Qipeng Luo, Xiaoxiao Guo, et al.. (2021). Predictive value of heart rate in patients with acute type A aortic dissection: a retrospective cohort study. BMJ Open. 11(11). e047221–e047221. 4 indexed citations

11.

Wang, Hanping, Jiaxin Zhou, Xiaoxiao Guo, et al.. (2020). Use of glucocorticoids in the management of immunotherapy‐related adverse effects. Thoracic Cancer. 11(10). 3047–3052. 17 indexed citations

12.

Lei, Chuxiang, Wenjun Xie, Yan Li, et al.. (2020). Oxidation of Ryanodine Receptors Promotes Ca ²⁺ Leakage and Contributes to Right Ventricular Dysfunction in Pulmonary Hypertension. Hypertension. 77(1). 59–71. 25 indexed citations

13.

Duan, Lian, Linjie Wang, Hanping Wang, et al.. (2020). Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction. Thoracic Cancer. 11(4). 1099–1104. 6 indexed citations

14.

Zhuang, Junling, Jianhua Du, Xiaoxiao Guo, et al.. (2020). Clinical diagnosis and treatment recommendations for immune checkpoint inhibitor‐related hematological adverse events. Thoracic Cancer. 11(3). 799–804. 29 indexed citations

15.

Si, Xiaoyan, Peng Song, Jun Ni, et al.. (2020). Management of immune checkpoint inhibitor‐related adverse events: A review of case reports. Thoracic Cancer. 11(3). 498–504. 14 indexed citations

16.

Lai, Jinzhi, Lin Zhao, Hui Zhong, et al.. (2020). Characteristics and Outcomes of Coronary Artery Involvement in Polyarteritis Nodosa. Canadian Journal of Cardiology. 37(6). 895–903. 11 indexed citations

17.

Si, Xiaoyan, Chun‐Xia He, Li Zhang, et al.. (2019). Management of immune checkpoint inhibitor‐related dermatologic adverse events. Thoracic Cancer. 11(2). 488–492. 19 indexed citations

18.

Wang, Hanping, Xiaoxiao Guo, Jiaxin Zhou, et al.. (2019). Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis. Thoracic Cancer. 11(1). 191–197. 67 indexed citations

19.

Lei, Chuxiang, Su Yuan, Wenlin Chen, et al.. (2019). Takayasu Arteritis With Coronary Artery Involvement: Differences Between Pediatric and Adult Patients. Canadian Journal of Cardiology. 36(4). 535–542. 18 indexed citations

20.

Wang, Hui, Xiaoxiao Guo, Zhuang Tian, et al.. (2016). Intracardiac thrombus in patients with Behcet’s disease: clinical correlates, imaging features, and outcome: a retrospective, single-center experience. Clinical Rheumatology. 35(10). 2501–2507. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact